NasdaqCM - Nasdaq Real Time Price USD
Inhibikase Therapeutics, Inc. (IKT)
At close: November 4 at 4:00 PM EST
After hours: November 4 at 5:55 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
19,005.3370
20,089.7920
18,128.6080
14,766.1400
2,818.4920
Operating Income
-19,005.3370
-20,089.7920
-18,128.6080
-14,766.1400
-2,818.4920
Net Non Operating Interest Income Expense
622.9550
1,060.9090
74.4530
-19.9230
-29.4020
Pretax Income
-18,382.3820
-19,028.8830
-18,054.1550
-14,786.0630
-2,847.8940
Net Income Common Stockholders
-18,382.3820
-19,028.8830
-18,054.1550
-14,786.0630
-2,847.8940
Diluted NI Available to Com Stockholders
-18,382.3820
-19,028.8830
-18,054.1550
-14,786.0630
-2,847.8940
Basic EPS
-3.21
-3.57
-4.28
-4.86
-2.10
Diluted EPS
-3.21
-3.57
-4.28
-4.86
-2.10
Basic Average Shares
5,861.0380
5,333.0960
4,223.0990
3,034.8660
1,368.7630
Diluted Average Shares
5,861.0380
5,333.0960
4,223.0990
3,034.8660
1,368.7630
Total Operating Income as Reported
-19,005.3370
-20,089.7920
-18,128.6080
-14,766.1400
-2,818.4920
Total Expenses
19,005.3370
20,089.7920
18,128.6080
14,766.1400
2,818.4920
Net Income from Continuing & Discontinued Operation
-18,382.3820
-19,028.8830
-18,054.1550
-14,786.0630
-2,847.8940
Normalized Income
-18,382.3820
-19,028.8830
-18,054.1550
-14,786.0630
-2,847.8940
Interest Income
622.9550
1,060.9090
74.4530
--
--
Interest Expense
0.1630
--
--
19.9230
29.4020
Net Interest Income
622.9550
1,060.9090
74.4530
-19.9230
-29.4020
EBIT
-19,005.3370
-20,089.7920
-18,128.6080
-14,766.1400
-2,818.4920
EBITDA
-18,979.0490
-19,912.3940
-18,121.8850
-14,766.1400
-2,818.4920
Reconciled Depreciation
26.2880
177.3980
6.7230
--
--
Net Income from Continuing Operation Net Minority Interest
-18,382.3820
-19,028.8830
-18,054.1550
-14,786.0630
-2,847.8940
Normalized EBITDA
-18,979.0490
-19,912.3940
-18,121.8850
-14,766.1400
-2,818.4920
12/31/2020 - 12/23/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MAIA MAIA Biotechnology, Inc.
2.8800
+4.73%
COYA Coya Therapeutics, Inc.
6.85
-2.70%
CALC CalciMedica, Inc.
3.5000
-0.28%
ATYR aTyr Pharma, Inc.
3.0800
+1.32%
LYRA Lyra Therapeutics, Inc.
0.2629
+1.55%
ANVS Annovis Bio, Inc.
8.73
-3.96%
XLO Xilio Therapeutics, Inc.
1.4400
+9.09%
ELDN Eledon Pharmaceuticals, Inc.
4.8300
-8.87%
UNCY Unicycive Therapeutics, Inc.
0.4799
-4.04%
CNTX Context Therapeutics Inc.
2.2300
-1.76%